| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/13/2006 | WO2006074479A1 Process for preparing tolterodine tartrate |
| 07/13/2006 | WO2006074478A1 Substantially pure tolterodine tartrate and process for preparing thereof |
| 07/13/2006 | WO2006073572A2 Treatment of conditions caused by calcium abnormalities |
| 07/13/2006 | WO2006073197A1 1-thio-d-glucitol derivatives |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006073147A1 Remedial agent for fat toxicity |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072881A1 Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
| 07/13/2006 | WO2006072354A1 Squaric acid derivatives |
| 07/13/2006 | WO2006030977A3 Imidazole derivatives as large conductance calcium-activated k channel openers |
| 07/13/2006 | WO2006008003A3 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154976 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 07/13/2006 | US20060154969 Adenosine receptor selective modulators |
| 07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 07/13/2006 | US20060154916 Condensed azepines as vasopressin agonists |
| 07/13/2006 | US20060154868 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/13/2006 | US20060153864 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 07/13/2006 | US20060153836 Using monoclonal antibody specific for kidney injury-molecule-1 (KIM-1) to diagnose, prevent and treat cell proliferative and kidney disorders; immunotherapeutics |
| 07/13/2006 | US20060153825 Use of protein histidine phosphatase |
| 07/13/2006 | US20060153794 Hair tonics and method of screening the same |
| 07/13/2006 | DE102004063797A1 Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide Oxygen-containing fused phenylpiperazine and Phenyldiazepancarboxamide |
| 07/13/2006 | CA2594433A1 Compositions comprising the 2s,4r ketoconazole enantiomer for treating diabetes, metabolic syndrome and other conditions |
| 07/13/2006 | CA2594388A1 Squaric acid derivatives |
| 07/13/2006 | CA2593768A1 Use of .omega.3 unsaturated fatty acids for relieving lipotoxicity |
| 07/13/2006 | CA2590556A1 Process for preparing tolterodine tartrate |
| 07/13/2006 | CA2590555A1 Substantially pure tolterodine tartrate and process for preparing thereof |
| 07/13/2006 | CA2587263A1 Treatment of conditions caused by calcium abnormalities |
| 07/12/2006 | EP1679310A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 07/12/2006 | EP1679296A1 Ether derivative |
| 07/12/2006 | EP1679081A2 Therapeutic application of cephaibols |
| 07/12/2006 | EP1516866B1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | EP1303499B1 Tetrazole derivatives |
| 07/12/2006 | CN1802345A Highly pure bases of 3,3-diphenyl propylamine monoesters |
| 07/12/2006 | CN1799614A Chinese traditional medicine composition for treating liver and kidney diseases and preparation method thereof |
| 07/12/2006 | CN1799612A Novel drug administering route of 'Qu Gan Re' injection, its preparation process and novel indications |
| 07/12/2006 | CN1799608A Application of essence-supplementing deer essence in preparation of medicine for treating prostate diseases |
| 07/12/2006 | CN1799595A Chinese medicinal formulation for treating urogenital system disease |
| 07/12/2006 | CN1799585A Intravenous administered formulation of spreading hedyotis herb and its preparation method |
| 07/12/2006 | CN1799572A Method for extracting biological active substances from bean embryo and its application |
| 07/12/2006 | CN1799563A Composition for treating benign prostate hyperplasia and related prostate diseases |
| 07/12/2006 | CN1799407A Aloe and pollen tablet and its production method |
| 07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 07/12/2006 | CN1263720C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
| 07/11/2006 | US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders. |
| 07/11/2006 | US7074780 Substituted phenylcyclohexanecarboxamides and their use |
| 07/11/2006 | US7074762 Contacting metanephric tissue with a growth factor-containing formulation comprising one or more growth factors for metanephric development for therapy of metanephric tissue that is transplanted into a recipient |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2198751C Dihydro-2,3-benzodiazepine derivatives |
| 07/11/2006 | CA2158609C 5 .alpha.-reductase inhibitors |
| 07/11/2006 | CA2129998C Improved amino acid solutions for treatment of peritoneal dialysis patients |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
| 07/06/2006 | WO2006070934A1 Crystal of bicyclic fused heterocyclic derivative, process for production thereof, and use thereof |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006070806A1 Novel benzimidazole compound and medicinal composition containing the compound |
| 07/06/2006 | WO2006070780A1 Par-2 agonist |
| 07/06/2006 | WO2006050314A3 Once a day formulation for phosphate binders |
| 07/06/2006 | US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 07/06/2006 | US20060148885 Medicinal composition |
| 07/06/2006 | US20060148844 Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation |
| 07/06/2006 | US20060148834 Novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 07/06/2006 | US20060148821 N,N-disubstituted diazocycloalkanes |
| 07/06/2006 | US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor |
| 07/06/2006 | US20060148802 Use of compounds that stimulate cgmp |
| 07/06/2006 | US20060148794 Neuropeptide Y antagonist; antiarthritic agents; cardiovascular disorders; antidiabetic agents; kidney disorders; eating disorders; obesity |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148791 Glutamate receptor antagonists |
| 07/06/2006 | US20060148760 Method for the sysnthesis of compounds of formula I and their uses thereof |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148732 Inhibition of NF-kappaB by triterpene compositions |
| 07/06/2006 | US20060148718 complex of cytotoxic agent to polypeptides; amino acid sequence proteolytic splitting protate specific antigen; therapy for protate cancer and benign prostate hyperplasia |
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/06/2006 | CA2590586A1 Substituted biaryl analogues |
| 07/05/2006 | EP1676855A2 Prenyl transferase inhibitors |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676839A2 Novel beta crystalline form of perindopril tert-butylamine salt, its preparation method and pharmaceutical compositions containing same |
| 07/05/2006 | EP1675617A1 Compositions and methods for augmenting kidney function |
| 07/05/2006 | EP1675603A1 Use of probiotic bacteria in the treatment of infection |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | EP1102838B1 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/05/2006 | CN1798746A Reverse-turn mimetics and method relating thereto |
| 07/05/2006 | CN1798723A Method for the treatment or prevention of lower urinary tract symptoms |
| 07/05/2006 | CN1795906A Composition for resisting stretch |
| 07/05/2006 | CN1795890A Medication for treating chronic nephritis and preparation method |
| 07/05/2006 | CN1795845A Slow release microsphere preparation of derivative of 3,3 ¿C diphenyl propylamine as receptor antagon of toadstool alkali in use for injection |
| 07/05/2006 | CN1262560C 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds |
| 07/05/2006 | CN1262547C Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods |
| 07/05/2006 | CN1262295C Health care medicine capable of strengthening heart and kidney function and immunologic function |
| 07/05/2006 | CN1262286C Method for extracting prostate cancer resisting active element from cole pollen |